Tissue Engineering The transtissue company Technology & Services Science & Development at transtissue Your contacts
 
 

TransTissue Technologies, founded as a spin-off of advanced developments at the University Medical Center Charité of Berlin's Humboldt University in February 2000, has been a subsidiary of BioTissue Technologies, Freiburg since September 2001.

With more than 15 years of experience in the field of tissue engineering, the scientists and founders of TransTissue Technologies have developed second-generation autologous tissue replacements, e.g. cartilage and bone grafts.

As a technology firm we are mainly concerned with inventions and the development of tissue engineering products for regenerative medicine as well as new platform technologies.